THE WIRE · № 77524
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
01 THE MACHINE READ
WHY IT MATTERS.
Clinical data presentations for a niche cryoablation device support adoption but carry no near-term revenue signal.
Small-cap device story, no financial figures disclosed
Peer-reviewed outcomes or reimbursement decisions
Promotional release with no commercial detail
FULL DISPATCH
Scientific presentations, research posters and clinical workshops featured ProSense® breast cancer cryoablation and highlighted strong physician engagement across Europe CAESAREA, Israel, October 13, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
A first step, but no real rebalancing in the European Union’s trade deal with China2026-10-12 15:16 UTC
IMF sees Montenegro's 2026 GDP growth quickening to 3.0%2026-10-13 08:54 UTC
Czech Core Inflation Quickens as Central Bank Mulls Another Hike2026-10-13 11:25 UTC
Polish central banker Duda keeps door open to near-term rate hike2026-10-13 11:59 UTC
NICHOLAS SHUBITZ | West’s decline may be more pronounced than GDP figures suggest2026-10-13 12:16 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.